telmisartan has been researched along with CACH Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chai, Q; Chen, Y; Cui, Y; Dong, Y; Duan, D; Gong, G; Hu, W; Ji, T; Liu, Z; Sheng, L; Sun, S; Wang, J; Zhang, H; Zhao, Y; Zhou, T | 1 |
1 trial(s) available for telmisartan and CACH Syndrome
Article | Year |
---|---|
Effects of sartans and low-dose statins on cerebral white matter hyperintensities and cognitive function in older patients with hypertension: a randomized, double-blind and placebo-controlled clinical trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Cognitive Dysfunction; Disease Progression; Double-Blind Method; Essential Hypertension; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukoencephalopathies; Male; Middle Aged; Rosuvastatin Calcium; Telmisartan | 2019 |